Eurocor launches APERTUS Aspiration Catheter for Optimal Thrombus Aspiration in STEMI patients
An innovative elliptic cross-sectional distal form that optimises the aspiration lumen and reduces friction with the guidewire catheter
Eurocor GmbH, an Opto Circuits group company, launched its Apertus Aspiration Catheter. The catheter is specifically designed for enhanced fast and accurate thrombus aspiration. Eurocor is marketing the new advice in more than 50 countries worldwide. Eurocor is an European medical device company specialized in cardiovascular and endovascular devices. The Apertus Aspiration Catheter complements Eurocor’s already broad cardiovascular intervention portfolio. Beside drug-coated balloons, stent delivery systems and dilatation catheters, Eurocor now offers an additional device for patient care to treat vascular disease.
Apertus offers an innovative elliptic cross-sectional distal form that optimises the aspiration lumen and reduces friction with the guidewire catheter. Apertus has one of the largest extraction lumen. Its smooth tip is specifically designed to increase deliverability and the innovative shaft brings excellent pushabilty. These features lead to enhanced efficacy with the highest aspiration speed, and excellent deliverability.
A choice of 2 sizes (6Fr or 7Fr guide catheter compatibility) is now available. The Apertus Aspiration Catheter is used to remove arterial thrombus, a formation of a blood clot inside arteries. The European Society of Cardiology (ESC) guidelines recommend using thrombus aspiration catheters in primary Percutaneous coronary intervention (PCI) as class II a treatment for patients suffering from Acute myocardial infarction (AMI).
The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend the aspiration treatment as therapy for ST-segment elevation myocardial infarction (STEMI) patients. Lalit Mamtani, CEO, Eurocor GmbH, commented: “The Aspiration Catheter is an ideal product that complements Eurocors product portfolio to offer the best treatment options for vascular interventions, especially for those challenging patient groups like STEMI patients, diabetic patients or patients suffering from small vessel disease in CAD or PAD.”
EH News Bureau
